Sequenom Raises $80M in Public Offering of Common Stock | GenomeWeb
This article has been updated to include net proceeds from the offering and additional historical stock data.
NEW YORK (GenomeWeb News) – Sequenom has gained net proceeds of roughly $80.1 million from Thursday's public offering of 5.5 million shares at $15.50 per share, a slight discount to Wednesday’s closing price of $15.94.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.